Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease (HBO)
Encephalopathy, White Matter Hyperintensities, Impaired Oxygen Delivery
About this trial
This is an interventional treatment trial for Encephalopathy focused on measuring Hyperbaric Oxygen, Small Vessel Disease of the Brain, Impaired Brain Circuit Connections
Eligibility Criteria
Inclusion Criteria: Over 50 years of age White Matter Hyperintensities on MRI @ or more symptoms and/or neurological impairments e.g. gait disturbances,disequilibrium, decline in cognitive function, upper motor neuron deficit, dysmetria, hyper-refexia or unilateral increase in motor tone -
Exclusion Criteria: Contraindications to hyperbaric oxygen therapy e.g. pulmonary emphysema or bullae, claustrophobiia, seizure diorder Inability of the patient to tolerate pressurization e.g. Eustachian tube dysfunction Stroke within the previous 6 months Extreme cognitive impairment Major depression Other uncontrolled co-morbidities, e.g. diabetes, hypertension, thyroid disorders, carotid artery stenosis (>70%), renal or hepatic dysfunction History of brain tumor, head trauma, electric shock therapy, brain irradiation History of migraine headaches
-
Sites / Locations
- St. Luke's Hospital
- St. Luke's Hospital
- Mallinckrodt Institute of Radiology/Washington University Medical School
Arms of the Study
Arm 1
Experimental
Hyperbaric Oxygen treatment
administration of 100% Oxygen at 2 Atmospheres Absolute for 1 hour 1 daily, 5 days a week for 2 weeks